Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (81-90 of 355) with videos related to

Pageof 36
Sort By:
Expert Review of Anticancer Therapy|February 19, 2008
Immunotherapy opportunities in ovarian cancerChristina S Chu, Sarah H Kim, Carl H June, et al.
Expert Opinion on Biological Therapy|January 3, 2015
Potential approaches for more successful dendritic cell-based immunotherapyCheryl Lai-Lai Chiang, Klara Balint, George Coukos, et al.
Frontiers in Immunology|August 22, 2022
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissuesElisabetta Cribioli, Greta Maria Paola Giordano Attianese, George Coukos, et al.
Critical Reviews in Biotechnology|November 15, 2014
Phage antibody display libraries: a powerful antibody discovery platform for immunotherapyAizhi Zhao, Mohammad R Tohidkia, Donald L Siegel, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2008
Mechanisms of microRNA deregulation in human cancerShan Deng, George Adrian Calin, Carlo M Croce, et al.
The Journal of Biological Chemistry|October 16, 2010
Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cellsXiaomin Zhong, Ning Li, Shun Liang, et al.
Micromachines|September 28, 2021
Microfluidic Device for Droplet Pairing by Combining Droplet Railing and Floating Trap ArraysMargaux Duchamp, Marion Arnaud, Sara Bobisse, et al.
Frontiers in Immunology|April 20, 2017
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the FuelMelita Irving, Romain Vuillefroy de Silly, Kirsten Scholten, et al.
Biometrics|February 12, 2008
Varying coefficient model with unknown within-subject covariance for analysis of tumor growth curvesRobert T Krafty, Phyllis A Gimotty, David Holtz, et al.
Oncoimmunology|July 29, 2016
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapyEmese Zsiros, Denarda Dangaj, Carl H June, et al.
Pageof 36

Showing results (81-90 of 355) with videos related to

Sort By:
Pageof 36
Expert Review of Anticancer Therapy|February 19, 2008
Immunotherapy opportunities in ovarian cancerChristina S Chu, Sarah H Kim, Carl H June, et al.
Expert Opinion on Biological Therapy|January 3, 2015
Potential approaches for more successful dendritic cell-based immunotherapyCheryl Lai-Lai Chiang, Klara Balint, George Coukos, et al.
Frontiers in Immunology|August 22, 2022
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissuesElisabetta Cribioli, Greta Maria Paola Giordano Attianese, George Coukos, et al.
Critical Reviews in Biotechnology|November 15, 2014
Phage antibody display libraries: a powerful antibody discovery platform for immunotherapyAizhi Zhao, Mohammad R Tohidkia, Donald L Siegel, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2008
Mechanisms of microRNA deregulation in human cancerShan Deng, George Adrian Calin, Carlo M Croce, et al.
The Journal of Biological Chemistry|October 16, 2010
Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cellsXiaomin Zhong, Ning Li, Shun Liang, et al.
Micromachines|September 28, 2021
Microfluidic Device for Droplet Pairing by Combining Droplet Railing and Floating Trap ArraysMargaux Duchamp, Marion Arnaud, Sara Bobisse, et al.
Frontiers in Immunology|April 20, 2017
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the FuelMelita Irving, Romain Vuillefroy de Silly, Kirsten Scholten, et al.
Biometrics|February 12, 2008
Varying coefficient model with unknown within-subject covariance for analysis of tumor growth curvesRobert T Krafty, Phyllis A Gimotty, David Holtz, et al.
Oncoimmunology|July 29, 2016
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapyEmese Zsiros, Denarda Dangaj, Carl H June, et al.
Pageof 36